392 related articles for article (PubMed ID: 19401434)
1. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.
Nagasumi K; Esaki R; Iwachidow K; Yasuhara Y; Ogi K; Tanaka H; Nakata M; Yano T; Shimakawa K; Taketomi S; Takeuchi K; Odaka H; Kaisho Y
Diabetes; 2009 May; 58(5):1067-76. PubMed ID: 19401434
[TBL] [Abstract][Full Text] [Related]
2. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.
Tan CP; Feng Y; Zhou YP; Eiermann GJ; Petrov A; Zhou C; Lin S; Salituro G; Meinke P; Mosley R; Akiyama TE; Einstein M; Kumar S; Berger JP; Mills SG; Thornberry NA; Yang L; Howard AD
Diabetes; 2008 Aug; 57(8):2211-9. PubMed ID: 18477808
[TBL] [Abstract][Full Text] [Related]
3. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
[TBL] [Abstract][Full Text] [Related]
4. CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients.
Sunil V; Verma MK; Oommen AM; Sadasivuni M; Singh J; Vijayraghav DN; Chandravanshi B; Shetty J; Biswas S; Dandu A; Moolemath Y; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2014 Mar; 15():19. PubMed ID: 24666736
[TBL] [Abstract][Full Text] [Related]
5. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.
Alquier T; Peyot ML; Latour MG; Kebede M; Sorensen CM; Gesta S; Ronald Kahn C; Smith RD; Jetton TL; Metz TO; Prentki M; Poitout V
Diabetes; 2009 Nov; 58(11):2607-15. PubMed ID: 19720802
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
8. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
[TBL] [Abstract][Full Text] [Related]
9. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells.
Welsh M; Christmansson L; Karlsson T; Sandler S; Welsh N
Mol Med; 1999 Mar; 5(3):169-80. PubMed ID: 10404514
[TBL] [Abstract][Full Text] [Related]
11. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
12. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ
Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438
[TBL] [Abstract][Full Text] [Related]
13. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo.
Latour MG; Alquier T; Oseid E; Tremblay C; Jetton TL; Luo J; Lin DC; Poitout V
Diabetes; 2007 Apr; 56(4):1087-94. PubMed ID: 17395749
[TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids.
Del Guerra S; Bugliani M; D'Aleo V; Del Prato S; Boggi U; Mosca F; Filipponi F; Lupi R
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):22-5. PubMed ID: 19758793
[TBL] [Abstract][Full Text] [Related]
15. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
[TBL] [Abstract][Full Text] [Related]
16. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
Doshi LS; Brahma MK; Sayyed SG; Dixit AV; Chandak PG; Pamidiboina V; Motiwala HF; Sharma SD; Nemmani KV
Metabolism; 2009 Mar; 58(3):333-43. PubMed ID: 19217448
[TBL] [Abstract][Full Text] [Related]
17. Combined Deletion of Free Fatty-Acid Receptors 1 and 4 Minimally Impacts Glucose Homeostasis in Mice.
Croze ML; Guillaume A; Ethier M; Fergusson G; Tremblay C; Campbell SA; Maachi H; Ghislain J; Poitout V
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33543237
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance.
Akerfeldt MC; Laybutt DR
Diabetes; 2011 Oct; 60(10):2506-14. PubMed ID: 21940780
[TBL] [Abstract][Full Text] [Related]
19. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
20. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
Schnell S; Schaefer M; Schöfl C
Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]